Towards Healthcare
Allergy Diagnostics And Therapeutics Market to Promote USD 84.59 Bn by 2035

Allergy Diagnostics And Therapeutics Market Accelerates with Innovation

Projections indicate that, the global allergy diagnostics and therapeutics market will increase from USD 36.55 billion in 2025 to USD 84.59 billion by 2035, experiencing a CAGR of 8.76% over the next 10 years. The market is growing due to the rising prevalence of allergic diseases and increasing demand for advanced diagnostic solutions and personalized treatments. North America dominates the market owing to strong healthcare infrastructure, high awareness, and widespread adoption of innovative allergy testing technologies.

Content

  • Last Updated: 11 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The allergy diagnostics and therapeutics market is worth USD 39.75 billion in 2026, and by 2035, it is forecasted to hit USD 84.59 billion, registering a CAGR of 8.76% over the decade.

North America is currently leading the allergy diagnostics and therapeutics market due to the high prevalence of allergic diseases, advanced healthcare infrastructure, and the strong presence of leading pharmaceutical and diagnostic companies.

The allergy diagnostics and therapeutics market includes 4 segments by type, by allergen type, by test type, and by region.

Key trends include the growth due to the rising prevalence of allergic diseases and increasing demand for advanced diagnostic solutions and personalized treatments.

The most common tests include skin prick tests, blood (IgE) tests, patch tests, and in vitro assays.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions